231 related articles for article (PubMed ID: 28689207)
1. Design of Finasteride-Loaded Nanoparticles for Potential Treatment of Alopecia.
Roque LV; Dias IS; Cruz N; Rebelo A; Roberto A; Rijo P; Reis CP
Skin Pharmacol Physiol; 2017; 30(4):197-204. PubMed ID: 28689207
[TBL] [Abstract][Full Text] [Related]
2. Lipid nanoparticles for topical and transdermal application for alopecia treatment: development, physicochemical characterization, and in vitro release and penetration studies.
Gomes MJ; Martins S; Ferreira D; Segundo MA; Reis S
Int J Nanomedicine; 2014; 9():1231-42. PubMed ID: 24634584
[TBL] [Abstract][Full Text] [Related]
3. Transdermal finasteride delivery via powder-carrying microneedles with a diffusion enhancer to treat androgenetic alopecia.
Kim S; Eum J; Yang H; Jung H
J Control Release; 2019 Dec; 316():1-11. PubMed ID: 31689460
[TBL] [Abstract][Full Text] [Related]
4. Finasteride Topical Delivery Systems for Androgenetic Alopecia.
Khan MZU; Khan SA; Ubaid M; Shah A; Kousar R; Murtaza G
Curr Drug Deliv; 2018; 15(8):1100-1111. PubMed ID: 29366416
[TBL] [Abstract][Full Text] [Related]
5. Design and in vitro evaluation of finasteride-loaded liquid crystalline nanoparticles for topical delivery.
Madheswaran T; Baskaran R; Thapa RK; Rhyu JY; Choi HY; Kim JO; Yong CS; Yoo BK
AAPS PharmSciTech; 2013 Mar; 14(1):45-52. PubMed ID: 23207960
[TBL] [Abstract][Full Text] [Related]
6. A Systematic Review of Topical Finasteride in the Treatment of Androgenetic Alopecia in Men and Women.
Lee SW; Juhasz M; Mobasher P; Ekelem C; Mesinkovska NA
J Drugs Dermatol; 2018 Apr; 17(4):457-463. PubMed ID: 29601622
[TBL] [Abstract][Full Text] [Related]
7. Chitosan-decorated polystyrene-b-poly(acrylic acid) polymersomes as novel carriers for topical delivery of finasteride.
Caon T; Porto LC; Granada A; Tagliari MP; Silva MA; Simões CM; Borsali R; Soldi V
Eur J Pharm Sci; 2014 Feb; 52():165-72. PubMed ID: 24262075
[TBL] [Abstract][Full Text] [Related]
8. Transdermal film-loaded finasteride microplates to enhance drug skin permeation: Two-step optimization study.
Ahmed TA; El-Say KM
Eur J Pharm Sci; 2016 Jun; 88():246-56. PubMed ID: 26993962
[TBL] [Abstract][Full Text] [Related]
9. Histological assessment of follicular delivery of flutamide by solid lipid nanoparticles: potential tool for the treatment of androgenic alopecia.
Hamishehkar H; Ghanbarzadeh S; Sepehran S; Javadzadeh Y; Adib ZM; Kouhsoltani M
Drug Dev Ind Pharm; 2016; 42(6):846-53. PubMed ID: 26154267
[TBL] [Abstract][Full Text] [Related]
10. Topical formulations containing finasteride. Part I: in vitro permeation/penetration study and in vivo pharmacokinetics in hairless rat.
Monti D; Tampucci S; Burgalassi S; Chetoni P; Lenzi C; Pirone A; Mailland F
J Pharm Sci; 2014 Aug; 103(8):2307-14. PubMed ID: 24942358
[TBL] [Abstract][Full Text] [Related]
11. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study.
Shanshanwal SJ; Dhurat RS
Indian J Dermatol Venereol Leprol; 2017; 83(1):47-54. PubMed ID: 27549867
[TBL] [Abstract][Full Text] [Related]
12. Physicochemical Characterization of Finasteride Nanosystem for Enhanced Topical Delivery.
Irfan MM; Shah SU; Khan IU; Munir MU; Khan NR; Shah KU; Rehman SU; Sohaib M; Basit HM; Mahmood S
Int J Nanomedicine; 2021; 16():1207-1220. PubMed ID: 33623383
[TBL] [Abstract][Full Text] [Related]
13. Design of polymeric nanoparticles and its applications as drug delivery systems for acne treatment.
Reis CP; Martinho N; Rosado C; Fernandes AS; Roberto A
Drug Dev Ind Pharm; 2014 Mar; 40(3):409-17. PubMed ID: 23480566
[TBL] [Abstract][Full Text] [Related]
14. Polymeric nanoparticles modified with fatty acids encapsulating betamethasone for anti-inflammatory treatment.
Silva CO; Rijo P; Molpeceres J; Figueiredo IV; Ascensão L; Fernandes AS; Roberto A; Reis CP
Int J Pharm; 2015 Sep; 493(1-2):271-84. PubMed ID: 26222745
[TBL] [Abstract][Full Text] [Related]
15. Effect of Binary Organic Solvents Together with Emulsifier on Particle Size and In vitro Behavior of Paclitaxel-Encapsulated Polymeric Lipid Nanoparticles.
Qin S; Sun X; Li F; Yu K; Zhou Y; Liu N; Zhao C; Teng L; Li Y
Curr Drug Deliv; 2018; 15(7):987-997. PubMed ID: 29268685
[TBL] [Abstract][Full Text] [Related]
16. Development of zolmitriptan loaded PLGA/poloxamer nanoparticles for migraine using quality by design approach.
Girotra P; Singh SK; Kumar G
Int J Biol Macromol; 2016 Apr; 85():92-101. PubMed ID: 26724690
[TBL] [Abstract][Full Text] [Related]
17. Fabrication and statistical optimization of surface engineered PLGA nanoparticles for naso-brain delivery of ropinirole hydrochloride: in-vitro-ex-vivo studies.
Patil GB; Surana SJ
J Biomater Sci Polym Ed; 2013; 24(15):1740-56. PubMed ID: 23705812
[TBL] [Abstract][Full Text] [Related]
18. Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date.
Iamsumang W; Leerunyakul K; Suchonwanit P
Drug Des Devel Ther; 2020; 14():951-959. PubMed ID: 32184564
[TBL] [Abstract][Full Text] [Related]
19. PLGA Nanoparticles as Subconjunctival Injection for Management of Glaucoma.
Salama HA; Ghorab M; Mahmoud AA; Abdel Hady M
AAPS PharmSciTech; 2017 Oct; 18(7):2517-2528. PubMed ID: 28224390
[TBL] [Abstract][Full Text] [Related]
20. Effects of a novel finasteride 0.25% topical solution on scalp and serum dihydrotestosterone in healthy men with androgenetic alopecia.
Caserini M; Radicioni M; Leuratti C; Terragni E; Iorizzo M; Palmieri R
Int J Clin Pharmacol Ther; 2016 Jan; 54(1):19-27. PubMed ID: 26636418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
